Zimmer Biomet will commercialize RevelAi’s artificial intelligence-powered care management platform, care team dashboard and future products. RevelAi’s products help streamline care workflows while addressing healthcare disparities, Christian Péan, MD, CEO of RevelAi Health, said in a June 12 news release.
“Our AI-enabled asynchronous care model delivers personalized, timely, and effective patient care while reducing clinician burnout,” he said. “Our collaboration with Zimmer Biomet is a significant step towards ensuring that every patient receives the care they deserve.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
